Compare Motorola Solutions Inc (MSI) vs Repligen Corporation Common Stock (RGEN) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Motorola Solutions Inc vs Repligen Corporation Common Stock — how do they compare? Motorola Solutions Inc trades at $455.97 (market cap $74.31B), while Repligen Corporation Common Stock trades at $178.15 (market cap $11.14B). The key difference: Motorola Solutions Inc is far larger — about 6.7× Repligen Corporation Common Stock's market cap, and Motorola Solutions Inc pays a 1.08% dividend while Repligen Corporation Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Motorola Solutions Inc for 101 Days and Repligen Corporation Common Stock for 0 Days on average.
| MSI | RGEN | |
|---|---|---|
Market Cap | $74.31B | $11.14B |
Volume | 847,711 | 1,259,263 |
Sector | Technology | Health |
52-Week High | $491.24 | $194.57 |
52-Week Low | $363.83 | $102.87 |
Typical Hold Time | 101 Days | 0 Days |
Enterprise Value | $83.22B | $11.02B |
Dividend Yield | 1.08% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Motorola Solutions (MSI) trades at $449.01, up 0.64% today, with a neutral technical signal. The company shows strong fundamentals: revenue grew to $11.68B in 2025, net income margin is 17.44%, and it has beaten EPS estimates for three consecutive quarters. Recent news includes a $1.5B acquisition of D-Fend Solutions and a $139M public safety contract in Louisiana, highlighting growth in defense and security segments. Cash flow from operations is robust at $2.84B, though net cash flow was negative due to significant investing activities.
Outlook is positive given analyst consensus of a $525.86 price target and 70.59% buy ratings, supported by record backlog and strategic acquisitions. Risks include high valuation multiples (P/E 35.38) and increased debt levels, with net cash flow turning negative in 2025-2026. The stock offers growth potential in mission-critical solutions but faces execution risks from integration of recent buys and competitive pressures.
RGEN trades at $175.42, up 1.66% today, with a neutral technical signal and key support at $173. The stock has consistently beaten earnings estimates in recent quarters, with Q3 2026 results due October 27. Revenue grew to $738.26M in 2025, though net income margin is modest at 5.29%. The company recently completed the acquisition of BioLife Solutions, signaling strategic expansion.
Outlook remains positive with strong analyst support (91.67% buy ratings) and a consensus price target of $173.86, though high valuation multiples (P/E 240.34) pose a risk. Earnings growth and integration of acquisitions are key catalysts, but investors face execution risks and market volatility.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Motorola Solutions Inc
Motorola Solutions, Inc. is a data communications and telecommunications equipment provider. The Company develops data capture, wireless, infrastructure, bar code scanning, two-way radios, and wireless broadband networks. Motorola also produces public safety and government products, voice and data communications products and systems, and wireless LAN securities.
Read more on MSI →About Repligen Corporation Common Stock
Repligen Corporation develops and manufactures bioprocessing tools and technologies used in biologic drug manufacturing, including filtration and perfusion systems, chromatography columns and resins, and process analytics instruments. Its products support upstream and downstream production workflows for modalities such as monoclonal antibodies, mRNA, and viral vectors.
Read more on RGEN →
